Ascendis Pharma Introduces Vision 2030

Strategic roadmap to achieve blockbuster status for multiple products and expand the Company’s engine for future innovation COPENHAGEN, Denmark, Jan. 07, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND)

Scroll to Top